MLM
54
3
EMR
57
3
LB
64
9
BAC
65
6
GS
49
4
FMC
37
3
GLW
49
3
UA
41
-4
TRV
59
7
INTU
58
-4
FIS
72
4
DOV
57
-2
ICE
74
4
ES
43
4
SBUX
45
2
RCL
66
2
CRM
39
5
PSX
50
6
EMC
71
18
A
44
3
MLM
54
3
EMR
57
3
LB
64
9
BAC
65
6
GS
49
4
FMC
37
3
GLW
49
3
UA
41
-4
TRV
59
7
INTU
58
-4
FIS
72
4
DOV
57
-2
ICE
74
4
ES
43
4
SBUX
45
2
RCL
66
2
CRM
39
5
PSX
50
6
EMC
71
18
A
44
3
Financhill
Back

Rhythm Pharmaceuticals 10K Form

Sell
36

RYTM
Rhythm Pharmaceuticals

Last Price:
$52.27
Seasonality Move:
-9.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RYTM News And Ratings

See the #1 stock for the next 7 days that we like better than RYTM

RYTM Financial Statistics

Sales & Book Value

Annual Sales: $130.1M
Cash Flow: $-18.8M
Price / Cash Flow: 0
Annual Sales: $0.35
Price / Book: 148.3

Profitability

EPS (TTM): -4.35000
Net Income (TTM): $-260.6M
Gross Margin: $116.8M
Return on Equity: -178.94%
Return on Assets: -75.35%

Rhythm Pharmaceuticals Earnings Forecast

Key Rhythm Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 7 years for RYTM is 89.73%.
  • The Selling, General & Administrative Expenses for RYTM have been equal to 110.90% of Gross Profit Margin.
  • The Research & Development expenses have been 182.87% of Revenue.
  • The Net Earning history of RYTM is -200.27% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 4 years.

Rhythm Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RYTM
CUSIP: 76243J
Website: rhythmtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.24
Quick Ratio: 2.94

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RYTM Technical Analysis vs Fundamental Analysis

Sell
36
Rhythm Pharmaceuticals (RYTM) is a Sell

Is Rhythm Pharmaceuticals a Buy or a Sell?